(XERS) Xeris Pharmaceuticals - Performance 118.4% in 12m
XERS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
34.40%
#30 in Peer-Group
Rel. Strength
95.03%
#382 in Stock-Universe
Total Return 12m
118.38%
#11 in Peer-Group
Total Return 5y
86.50%
#22 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 5.87 USD |
| 52 Week Low | 2.13 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 81.66 |
| Buy/Sell Signal +-5 | -1.39 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: XERS (118.4%) vs XLV (-6.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.9% | 131% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
2.5% | 13.5% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-1.93% | -14.5% | 419% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.79% | 0.39% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-8.02% | 2.74% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-3.54% | -6.89% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-6.74% | -9.61% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
3.73% | 19% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: XERS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for XERS
| Total Return (including Dividends) | XERS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 16.67% | 0.06% | 4.01% |
| 3 Months | 22.84% | -0.76% | 17.14% |
| 12 Months | 118.38% | -6.69% | 13.46% |
| 5 Years | 86.50% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | XERS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 92.8% | 32.3% | 90.3% |
| 3 Months | 48.5% | -15.4% | 97.5% |
| 12 Months | 94.2% | -78.9% | 46.4% |
| 5 Years | -12.8% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th86.00 | 16.59% | 12.17% |
| 3 Month | %th60.50 | 23.77% | 4.86% |
| 12 Month | %th95.00 | 134.04% | 92.47% |
| 5 Years | %th89.50 | 29.09% | -12.33% |
FAQs
Does Xeris Pharmaceuticals (XERS) outperform the market?
Yes,
over the last 12 months XERS made 118.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.69%.
Over the last 3 months XERS made 22.84%, while XLV made -0.76%.
Performance Comparison XERS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
XERS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.3% | 12.7% | 47.9% | 105% |
| US NASDAQ 100 | QQQ | 8.3% | 12.5% | 45.9% | 105% |
| German DAX 40 | DAX | 7.9% | 15.5% | 35.8% | 88% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.1% | 12.1% | 43.4% | 100% |
| Hongkong Hang Seng | HSI | 7.4% | 13.8% | 25.9% | 83% |
| India NIFTY 50 | INDA | 9.6% | 17.5% | 47.4% | 121% |
| Brasil Bovespa | EWZ | 12.5% | 17.3% | 32.9% | 117% |
XERS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.7% | 15% | 44.6% | 95% |
| Consumer Discretionary | XLY | 7.3% | 13.3% | 55.6% | 100% |
| Consumer Staples | XLP | 10.3% | 16.8% | 48.8% | 111% |
| Energy | XLE | 5.3% | 12.5% | 55.5% | 116% |
| Financial | XLF | 9.7% | 14% | 45.6% | 93% |
| Health Care | XLV | 8.1% | 16.6% | 59.4% | 125% |
| Industrial | XLI | 7.9% | 12.2% | 42.1% | 95% |
| Materials | XLB | 7.6% | 12.2% | 47.3% | 114% |
| Real Estate | XLRE | 8.5% | 16.8% | 49.4% | 110% |
| Technology | XLK | 8.4% | 10% | 42.8% | 107% |
| Utilities | XLU | 8.2% | 14.1% | 43.9% | 98% |
| Aerospace & Defense | XAR | 7.6% | 9.8% | 27.9% | 69% |
| Biotech | XBI | 4.6% | 13.5% | 58.1% | 130% |
| Homebuilder | XHB | 5.2% | 7.9% | 54.5% | 119% |
| Retail | XRT | 8.3% | 13.4% | 52.7% | 112% |
XERS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.7% | 13.4% | 61.8% | 123% |
| Natural Gas | UNG | 10% | 23.1% | 73.9% | 120% |
| Gold | GLD | 8.1% | 16.4% | 30% | 80% |
| Silver | SLV | 3.9% | 10.4% | 25.9% | 96% |
| Copper | CPER | -2.1% | 1.7% | 28.4% | 95% |
XERS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.1% | 16.7% | 53.2% | 123% |
| iShares High Yield Corp. Bond | HYG | 8.8% | 15.5% | 50.9% | 109% |